PGFC
AZN icon

Peapack-Gladstone Financial Corp’s AstraZeneca AZN Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
72,990
+730
+1% +$137K 0.16% 146
2026
Q1 		$14.3M Buy
72,260
+923
+1% +$178K 0.18% 130
2025
Q4 		$13.1M Sell
71,337
-873
-1% -$153K 0.17% 139
2025
Q3 		$11.1M Buy
72,210
+3,011
+4% +$456K 0.14% 147
2025
Q2 		$9.67M Buy
69,199
+2,277
+3% +$319K 0.14% 153
2025
Q1 		$9.84M Buy
66,922
+15,914
+31% +$2.3M 0.15% 146
2024
Q4 		$6.68M Sell
51,008
-23,795
-32% -$3.33M 0.1% 181
2024
Q3 		$11.7M Buy
74,803
+11,580
+18% +$1.87M 0.17% 135
2024
Q2 		$9.86M Buy
63,223
+46,775
+284% +$7.04M 0.15% 144
2024
Q1 		$2.23M Buy
16,448
+344
+2% +$45.6K 0.03% 310
2023
Q4 		$2.17M Sell
16,104
-181
-1% -$23.5K 0.04% 308
2023
Q3 		$2.21M Buy
16,285
+123
+0.8% +$16.8K 0.04% 290
2023
Q2 		$2.31M Buy
16,162
+205
+1% +$30.2K 0.04% 284
2023
Q1 		$2.21M Sell
15,957
-32
-0.2% -$4.3K 0.04% 290
2022
Q4 		$2.17M Buy
15,989
+1,749
+12% +$219K 0.04% 286
2022
Q3 		$1.56M Sell
14,240
-1,445
-9% -$183K 0.03% 318
2022
Q2 		$2.07M Hold
15,685
– – 0.05% 262
2022
Q1 		$2.09M Buy
15,685
+1,568
+11% +$188K 0.04% 278
2021
Q4 		$1.65M Sell
14,117
-253
-2% -$29.8K 0.03% 309
2021
Q3 		$1.73M Buy
14,370
+5,161
+56% +$601K 0.04% 293
2021
Q2 		$1.1M Sell
9,209
-17
-0.2% -$1.86K 0.03% 325
2021
Q1 		$918K Buy
+9,226
New +$927K 0.02% 332

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Peapack-Gladstone Financial Corp's AZN Position: Q2 2026 in Review

Peapack-Gladstone Financial Corp increased its AstraZeneca (AZN) stake by 1% in Q2 2026, buying an estimated $137K and bringing the position to 72,990 shares worth $13.8M. The position accounts for 0.16% of the portfolio, ranked #146.

Peapack-Gladstone Financial Corp first reported a position in AZN in Q1 2021 and has held it in 22 quarters since. The position peaked at $14.3M in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Peapack-Gladstone Financial Corp held 72,990 shares of AstraZeneca worth $13.8M as of Q2 2026.
  • Peapack-Gladstone Financial Corp bought 730 AstraZeneca shares in Q2 2026, an estimated $137K.
  • AstraZeneca made up 0.16% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #146 holding.
  • Peapack-Gladstone Financial Corp first reported a position in AstraZeneca in Q1 2021 and has held it in 22 quarters since.
  • Peapack-Gladstone Financial Corp's AstraZeneca position peaked at $14.3M in Q1 2026.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.